Publish in this journal
Journal Information
Issue
Vol. 13. Issue 5.
Pages 249-310 (September - October 2017)
Sumario en español
Editorial
What lies in the near future for the treatment of rheumatoid arthritis?
Hèctor Corominas, Robert H. Shmerling
Reumatol Clin. 2017;13:249-51
Original articles
Profile of Patients With Fibromyalgia Being Treated in Primary Care Centers in Terrassa, a City in Northeastern Spain
Teresa Mur Martí, Montse Llordés Llordés, Mercè Custal Jordà, Gemma López Juan, Silvia Martínez Pardo
Reumatol Clin. 2017;13:252-7
A Comparative Study Between the Implementation of the FRIDEX Calibration and the NOGG Guideline in the Management of Osteoporosis in Routine Clinical Practice
Georgios Kyriakos, Alfonso Vidal-Casariego, Lourdes Victoria Quiles-Sánchez, Alicia Calleja-Fernández, Dalia Ávila-Turcios, Juan Andrés Urosa-Maggi, María D. Ballesteros-Pomar, Isidoro Cano-Rodríguez
Reumatol Clin. 2017;13:258-63
Recommendations for the Evaluation and Management of Patients With Rheumatic Autoimmune and Inflammatory Diseases During the Reproductive Age, Pregnancy, Postpartum and Breastfeeding
Juan Antonio Martínez López, M. Luz García Vivar, Rafael Cáliz, Mercedes Freire, María Galindo, Maria Victoria Hernández, Francisco Javier López Longo, Víctor Martínez Taboada, Jose María Pego Reigosa, Esteban Rubio, Elisa Trujillo, Paloma Vela-Casasempere
Reumatol Clin. 2017;13:264-81
How many patients with rheumatic diseases and TNF inhibitors treatment have latent tuberculosis?
Noemi Busquets-Pérez, Andrés Ponce, Vera Ortiz-Santamaria, Juanjosé de Agustín de Oro, Yolanda León Hernández-Rico, Imma Vidal, Carolina Alfonso, Sonia Argemí, Blanca Muñoz, Fernando Quispe, Ana Carolina Díaz, Salvador Campos, Teresa Mariné Hernández, Miquel Torres, Xavier Surís
Reumatol Clin. 2017;13:282-6
Review article
Biosimilars: A New Scenario in Biologic Therapies
José M. Serra López-Matencio, Alberto Morell Baladrón, Santos Castañeda
Reumatol Clin. 2017;13:287-93
Case reports
Relapsed Hydroxychloroquine Induced Thrombocytopenia in Systemic Lupus Erythematosus Patient
Vanesa Antón Vázquez, Luis Pascual, Héctor Corominas Macias, Isabel Giménez Torrecilla
Reumatol Clin. 2017;13:294-6
Leukocytoclastic Vasculitis and Infection. Report of a Case
María Jose Moreno Martínez, Deseada Palma Sánchez, Elena Peñas Martínez, Ana Haro Martínez, Marta Mayor González
Reumatol Clin. 2017;13:297-8
Images in clinical rheumatology
Van Neck-Odelberg Disease: Another Cause of Limp in Childhood
Isla Morante Bolado, Marina Ortega Navaridas, Daniel Clemente Garulo, Juan Carlos López Robledillo
Reumatol Clin. 2017;13:299-300
Painful Subcutaneous Nodule
Jorge Santos-Juanes, Cristina Galache, Veronica Blanco
Reumatol Clin. 2017;13:301-2
Fibrodysplasia Ossificans Progressiva: Case Report of a Terminal Patient
María del Mar Muñoz Gómez, Marta Novella Navarro, Fernando Ruiz Santiago, Enrique Raya Álvarez
Reumatol Clin. 2017;13:303-4
Letters to the editor
A Step Forward in Methotrexate Pharmacogenetics
Patricia Moya, Hèctor Corominas, Juliana Salazar, César Díaz-Torné
Reumatol Clin. 2017;13:305
Vocal cord palsy as a clinical manifestation of Behçet's disease
Elvis Amao-Ruiz, Ana María Correa-Fernández, Jesús Gallego-Gil
Reumatol Clin. 2017;13:306-7
Osteosarcoma in Tophaceous Gout: A Case Report and Literature Review
Enrique Calvo Aranda, Irene Rodríguez Pérez, Jesús Rodríguez-Pascual, Paloma García de la Peña Lefebvre
Reumatol Clin. 2017;13:307-9
Idiomas
Reumatología Clínica (English Edition)

Subscribe to our newsletter

es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.